TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer’s disease

ISSN： 0300-9564

Source： Journal of Neural Transmission, Vol.113, Iss.11, 2006-11, pp. : 1709-1715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Editorial – 100 years of Alzheimer’s disease

By Riederer Peter Hoyer Siegfried

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1595-1595

Springer Publishing Company

Access to resources Recommend Favorite

S100B-Mediated Inhibition of the Phosphorylation of GFAP Is Prevented by TRTK-12

By Frizzo Juliana Karl Tramontina Francine Bortoli Erica Gottfried Carmen Leal Rodrigo B. Lengyel Imre Donato Rosario Dunkley Peter R. Gonçalves Carlos-Alberto

Neurochemical Research, Vol. 29, Iss. 4, 2004-04 ,pp. : 735-740

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer’s disease

By Gazzaley Adam Small Scott A.

Network: Computation in Neural Systems, Vol. 22, Iss. 1-4, 2011-03 ,pp. : 173-185

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of Alzheimer’s disease and cerebral palsy: implications of the apolipoprotein E genotype

By Wainwright Mark S

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 353-356

Future Medicine

Access to resources Recommend Favorite

Gene expression profile in streptozotocin rat model for sporadic Alzheimer’s disease

By Grünblatt E. Hoyer S. Riederer P.

Journal of Neural Transmission, Vol. 111, Iss. 3, 2004-03 ,pp. : 367-386

Springer Publishing Company

Access to resources Recommend Favorite